Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
McGranahan, Nicholas; Rosenthal, Rachel; Hiley, Crispin T; Rowan, Andrew J; Watkins, Thomas B K; Wilson, Gareth A; Birkbak, Nicolai J; Veeriah, Selvaraju; Van Loo, Peter; Herrero, Javier; Swanton, Charles.
; 171(6): 1259-1271.e11, 2017 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-29107330
Lung Cancer: A Wily Genetic Opponent.
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.
Genomic landscape of non-small cell lung cancer in smokers and never-smokers.
Metabolic Heterogeneity in Human Lung Tumors.
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
The biology and management of non-small cell lung cancer.
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.
Postoperative radiotherapy for non-small cell lung cancer.